Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,844 | -75,153 | -48,279 | -165,867 | -118,395 |
| Depreciation Amortization | -1,750 | -1,393 | -772 | -2,977 | -5,633 |
| Accounts receivable | 5,000 | 5,000 | 5,000 | -5,000 | N/A |
| Other Working Capital | -7,744 | -6,574 | 1,754 | -16,540 | -9,464 |
| Other Operating Activity | 12,031 | 10,776 | 9,661 | 19,524 | 2,334 |
| Operating Cash Flow | $-94,307 | $-67,344 | $-32,636 | $-170,860 | $-131,158 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 98,605 | 70,284 | 40,470 | 176,717 | 144,434 |
| PPE Investments | 569 | 569 | 5 | -156 | -156 |
| Investing Cash Flow | $99,174 | $70,853 | $40,475 | $176,561 | $144,278 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 304 | 189 | 189 | 349 | 349 |
| Other Financing Activity | 0 | 0 | 0 | -241 | -241 |
| Financing Cash Flow | $304 | $189 | $189 | $108 | $108 |
| Beginning Cash Position | 36,528 | 36,528 | 36,528 | 30,719 | 30,719 |
| End Cash Position | 41,699 | 40,226 | 44,556 | 36,528 | 43,947 |
| Net Cash Flow | $5,171 | $3,698 | $8,028 | $5,809 | $13,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,307 | -67,344 | -32,636 | -170,860 | -131,158 |
| Capital Expenditure | N/A | 0 | N/A | -221 | -221 |
| Free Cash Flow | -94,307 | -67,344 | -32,636 | -171,081 | -131,379 |